Guillaume Germain

14PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsCell physiologySystems physiologyEmergency medicineOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 19, 2026
FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study.

Jadwiga A Wedzicha, Stephen G Noorduyn, Valentina Di Boscio

|Nov 30, 2025
Economic impact of using cariprazine as the first versus subsequent adjunctive therapy for Medicaid beneficiaries with major depressive disorder.

Prakash S Masand, Anita H Clayton, Mousam Parikh

|Jul 06, 2025
Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.

Jadwiga A Wedzicha, Stephen G Noorduyn, Valentina Di Boscio

|Jan 22, 2025
Healthcare resource utilization and costs of using cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder.

Prakash S Masand, Anita H Clayton, Mousam Parikh

|Dec 28, 2024
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.

David Mannino, Stephen Weng, Guillaume Germain

|Dec 05, 2024
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data.

Corinne Young, Lydia Y Lee, Kristi K DiRocco

Pageof 3

Frequent Collaborators

10 joint publications

François Laliberté

5 joint publications

Stephen G Noorduyn

5 joint publications

Rosirene Paczkowski

4 joint publications

David Mannino